These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16766395)

  • 1. Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity.
    Flisiak I; Klepacki A; Chodynicka B
    Biomarkers; 2006; 11(2):194-200. PubMed ID: 16766395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity.
    Flisiak I; Zaniewski P; Chodynicka B
    Biomarkers; 2008 Aug; 13(5):549-56. PubMed ID: 18979644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions.
    Flisiak I; Chodynicka B; Porebski P; Flisiak R
    Cytokine; 2002 Aug; 19(3):121-5. PubMed ID: 12242078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy.
    Flisiak I; Porebski P; Flisiak R; Chodynicka B
    Biomarkers; 2003; 8(5):437-43. PubMed ID: 14602527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
    Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
    Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
    Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score.
    Pietrzak A; Lecewicz-Torun B; Chodorowska G; Rolinski J
    Acta Derm Venereol; 2003; 83(4):262-5. PubMed ID: 12926796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab and methotrexate affect the concentrations of regulatory cytokines (interleukin-10, transforming growth factor-β1, and interleukin-35) in patients with plaque psoriasis.
    Zdanowska N; Owczarczyk-Saczonek A; Czerwińska J; Nowakowski JJ; Kozera-Żywczyk A; Owczarek W; Zdanowski W; Placek W
    Dermatol Ther; 2020 Nov; 33(6):e14153. PubMed ID: 32770629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales.
    Flisiak I; Porebski P; Chodynicka B
    Acta Derm Venereol; 2006; 86(1):17-21. PubMed ID: 16585983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
    Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
    Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.
    Meki AR; Al-Shobaili H
    J Clin Lab Anal; 2014 Nov; 28(6):496-501. PubMed ID: 24659464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
    Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
    Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of transforming growth factor-beta1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs.
    Kallimanis PG; Xenos K; Markantonis SL; Stavropoulos P; Margaroni G; Katsambas A; Avgerinou G
    Clin Exp Dermatol; 2009 Jul; 34(5):582-6. PubMed ID: 19094132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease.
    Purzycka-Bohdan D; Szczerkowska-Dobosz A; Zablotna M; Wierzbicka J; Piotrowska A; Zmijewski MA; Nedoszytko B; Nowicki R
    PLoS One; 2016; 11(10):e0165577. PubMed ID: 27788245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia.
    Malaguarnera L; Motta M; Di Rosa M; Anzaldi M; Malaguarnera M
    Neuropathology; 2006 Aug; 26(4):307-12. PubMed ID: 16961066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity.
    Michalak-Stoma A; Bartosińska J; Kowal M; Raczkiewicz D; Krasowska D; Chodorowska G
    Mediators Inflamm; 2020; 2020():7420823. PubMed ID: 32587472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Concentrations of Interferon Gamma (IFN-γ) in Patients with Psoriasis: Correlation with Clinical Type and Severity of the Disease.
    Kurtovic NO; Halilovic EK
    Med Arch; 2018 Dec; 72(6):410-413. PubMed ID: 30814771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.
    Flisiak I; Zaniewski P; Rogalska M; Myśliwiec H; Jaroszewicz J; Chodynicka B
    Cytokine; 2010 Dec; 52(3):225-9. PubMed ID: 20980160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris.
    Nockowski P; Szepietowski JC; Ziarkiewicz M; Baran E
    Acta Dermatovenerol Croat; 2004; 12(1):2-6. PubMed ID: 15072741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in patients with plaque-type psoriasis: lack of an association with plasma cytokines.
    Skoie IM; Dalen I; Kvivik I; Bårdsen K; Omdal R
    Eur J Dermatol; 2020 Feb; 30(1):16-23. PubMed ID: 32250252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.